Oral solid pharmaceutical form with sequential action for the administering of drugs with ulcerogenic side effect
申请人:LABORATORIO ITALIANO BIOCHIMICO
FARMACEUTICO LISAPHARMA S.P.A.
公开号:EP0167958A2
公开(公告)日:1986-01-15
Oral solid pharmaceutical form with antiinflammatory and analgesic activity, with sequential action, with protective effect on the gastric and duodenal mucosa against the action of the active principles having ulcerogenic effect, contained in the same pharmaceutical form.
Said pharmaceutical form is constituted by a tablet comprising: (a) a centre core containing an active principle provided with antiinflammatory and analgesic activity, with ulcerogenic side effects; (b) a layer coating of said core, containing a second active principle provided with protective action for said gastric and duodenal mucosa, which is immediately released.
具有消炎和镇痛活性的口服固体药剂,具有连续作用,对胃和十二指肠粘膜具有保护作用,防止具有致溃疡作用的活性成分对胃和十二指肠粘膜的作用,包含在同一药剂中。 所述药剂由片剂构成,片剂包括:(a)中心芯,内含具有消炎和镇痛活性的活性成分,具有致溃疡副作用;(b)所述中心芯的包衣层,内含对所述胃和十二指肠粘膜具有保护作用的第二种活性成分,可立即释放。